CoChat
Sign Up
Cited by 15

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who inject drugs in the United States from 2002 to 2019

Marotta, Phillip L., Stringer, Kristi, Beletsky, Leo, West, Brooke S., Goddard-Eckrich, Dawn, Gilbert, Louisa, Hunt, Tim, Wu, Elwin, El-Bassel, Nabila·2021·Harm Reduction Journal
DOI 10.1186/s12954-021-00565-6PMC PMC8600731
Open this paper in CoChat — free account

Abstract

Provision of sterile syringes is an evidence-based strategy of reducing syringe sharing and reusing and yet, access to sterile syringes through pharmacies and syringe exchange programs (SEPs) in the United States remains inadequate. This nationally representative study examined associations between obtaining syringes from pharmacies, SEPs, and sterilizing syringes with bleach and risk of syringe borrowing, lending and reusing syringes in a pooled cross-sectional dataset of 1737 PWID from the 2002–2019 National Survey on Drug Use and Health. Logistic regression was used to produce odds ratios (OR) of the odds of injection drug behaviors after adjusting for obtaining syringes from SEPs, pharmacies, the street, and other sources and potential confounders of race, ethnicity, sex, education, and insurance coverage. Obtaining syringes through SEPs was associated with lower odds of borrowing (OR = .4, CI 95% = .2, .9, p = .022) and reusing syringes (OR = .3, CI 95% = .2, .6, < .001) compared to obtaining syringes on the street. Obtaining syringes from pharmacies was associated with lower odds of borrowing (OR = .5, CI 95% = .3, .9, p = .037) and lending (OR = .5 CI 95% = .3, .9, p = .020) syringes. Using bleach to clean syringes was associated with increased odds of borrowing (OR = 2.0, CI 95% = 1.3, 3.0, p = .002), lending (OR = 2.0, CI 95% = 1.3, 3.0, p = .002) and reusing syringes (OR = 2.4, CI 95% = 1.6, 3.6, p < .001). Our findings support provision of syringes through pharmacies and SEPs as a gold-standard strategy of reducing sharing and reuse of syringes in the US.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12954-021-00565-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 36

  1. Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD. Cribbin M (2014) National HIV behavioral surveillance system study group: HIV infection and risk, prevention, and testing behaviors among injecting drug users—National HIV Behavioral Surveillance System, 20 US cities. Morb Mortal Wkly Rep Recomm Rep. 2009;63(6):1–51.
  2. Chiarello E. Nonprescription syringe sales: resistant pharmacists’ attitudes and practices. Drug Alcohol Depend. 2016;166:45–50. · DOI
  3. Collins AB, Boyd J, Cooper HL, McNeil R. The intersectional risk environment of people who use drugs. Soc Sci Med. 2019;234:112384. · DOI
  4. Cooper HL. War on drugs policing and police brutality. Subst Use Misuse. 2015;50(8–9):1188–94. · DOI
  5. Cooper HL, et al. National HIV Behavioral Surveillance Study Group: racialized risk environments in a large sample of people who inject drugs in the United States. Int J Drug Policy. 2016;27:43–55. · DOI
  6. Cooper HL, et al. National HIV Behavioral Surveillance Study Group: risk environments, race/ethnicity, and HIV status in a large sample of people who inject drugs in the United States. PLoS ONE. 2016;11(3):e0150410. · DOI
  7. Crawford ND, Myers S, Young H, Klepser D, Tung E. The role of pharmacies in the HIV prevention and care continuums: a systematic review. AIDS Behav. 2021. https://doi.org/10.1007/s10461-020-03111-w. · DOI
  8. DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, Sherman S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357–74. · DOI
  9. Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104(9):1441–6. · DOI
  10. Janulis P. Pharmacy nonprescription syringe distribution and HIV/AIDS: a review. J Am Pharm Assoc. 2012;52(6):787–97. · DOI
  11. Jarlais DC, Cooper HL, Bramson H, Deren S, Hatzakis A, Hagan H. Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs. Curr Opin HIV AIDS. 2012;7(4):354–61. · DOI
  12. Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc (1996). 2002;42(6):S83–7. · DOI
  13. Friedman SR, Cooper HL, Tempalski B, Keem M, Friedman R, Flom PL, Des Jarlais DC. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006;20(1):93–9. · DOI
  14. Fuller CM, Ahern J, Vadnai L, Coffin PO, Galea S, Factor SH, Vlahov D. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (1996). 2002;42(6):S77–82. · DOI
  15. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15(11):1329–41. · DOI
  16. Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two-to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr (1999). 2002;31(2):237–42. · DOI
  17. Hammett TM, Phan S, Gaggin J, Case P, Zaller N, Lutnick A, et al. Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries. BMC Health Serv Res. 2014;14(1):1–11. · DOI
  18. Havens JR, Walker R, Leukefeld CG. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend. 2007;87(1):98–102. · DOI · Paper page
  19. Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, Wood E. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100(8):1449–53. · DOI
  20. Maher L, Dixon TC. Collateral damage and the criminalisation of drug use. Lancet HIV. 2017;4(8):e326–7. · DOI
  21. Mennis J, Stahler GJ, Mason MJ. Risky substance use environments and addiction: a new frontier for environmental justice research. Int J Environ Res Public Health. 2016;13(6):607. · DOI
  22. Meyerson BE, Davis A, Agley JD, Shannon DJ, Lawrence CA, Ryder PT, et al. Predicting pharmacy syringe sales to people who inject drugs: policy, practice and perceptions. Int J Drug Policy. 2018;56:46–53. · DOI
  23. Muñoz F, Burgos JL, Cuevas-Mota J, Teshale E, Garfein RS. Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego. AIDS Behav. 2015;19(1):199–210. · DOI
  24. Murthy VH. Ending the opioid epidemic—a call to action. N Engl J Med. 2016;375(25):2413–5. · DOI
  25. Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J Urban Health. 2008;85(3):309–22. · DOI · Paper page
  26. Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104–10. · DOI · Paper page
  27. Rivera AV, DeCuir J, Crawford ND, Amesty S, Lewis CF. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010–2012. Drug Alcohol Depend. 2014;144:259–64. · DOI
  28. Sawangjit R, Khan TM, Chaiyakunapruk N. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis. Addiction. 2017;112(2):236–47. · DOI
  29. Singer M, Himmelgreen D, Weeks MR, Radda KE, Martinez R. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Med Anthropol. 1997;18(1):107–30. · DOI
  30. Springer SA, Korthuis PT, Del Rio C. Integrating treatment at the intersection of opioid use disorder and infectious disease epidemics in medical settings: a call for action after a national academies of sciences, engineering, and medicine workshop. Ann Intern Med. 2018;169:335. · DOI
  31. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, Hankins CA. HIV and risk environment for injecting drug users: the past, present, and future. The Lancet. 2010;376(9737):268–84. · DOI
  32. Stein MD, Anderson B. Injection frequency mediates health service use among persons with a history of drug injection. Drug Alcohol Depend. 2003;70(2):159–68. · DOI
  33. Tempalski B, Flom PL, Friedman SR, Des Jarlais DC, Friedman JJ, McKnight C, Friedman R. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health. 2007;97(3):437–47. · DOI
  34. Tempalski B, Williams LD, West BS, Cooper HL, Beane S, Ibragimov U, Friedman SR. Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993–2007. Substance Abuse Treat Prev Policy. 2020;15(1):1–16. · DOI
  35. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271(2):115–20. · DOI
  36. Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16(6):941–3. · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Marotta, P. L., Stringer, K., Beletsky, L., West, B. S., Goddard-Eckrich, D., Gilbert, L., Hunt, T., Wu, E., & El-Bassel, N.
Venue
Harm Reduction Journal
Publisher
Springer Science and Business Media LLC
Published
2021-11-17
Volume
18
Issue
1
ISSN
1477-7517
DOI
10.1186/s12954-021-00565-6
PMC
PMC8600731
Cited by
15
References
1
Language
en
Licence
Funders
National Institute on Drug Abuse (R25037190, F31DA044794, T32019426, T32037801)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review